- Curbing Overpriced Treatments for Cancer Care. Dr. Peter Bach from the department of Epidemiology-Biostatistics is mentioned in this article from The Fiscal Times.
- Memorial Sloan-Kettering Dx Molecular Pathology Lab Developing Cancer Panels on Illumina. Drs. Cyrus Hedvat, Michael Berger, and Ross Levine are mentioned.
- A letter in The New York Times entitled “In Cancer Care, Cost Matters” written by Peter B. Bach, Leonard B. Saltz, and Robert E. Wittes, doctors from MSKCC discuss their reason to not support an expensive new cancer drug.